{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:22:35Z","timestamp":1790446955807,"version":"4.1.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-66128-6","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:32:20Z","timestamp":1786123940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrating retinal and brain imaging biomarkers for diagnosis of parkinson\u2019s disease: findings from a time-lagged cross-sectional persian cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Farzane","family":"Nikparast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooshin","family":"Akbari-Sharak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Ganji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shoeibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Shoeibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"336","key":"66128_CR1","first-page":"780","volume":"33","author":"M Hosseini","year":"2015","unstructured":"Hosseini, M., Rajaei, Z. & Alaei, H. Effects of Crocin on Rotational Behavior, Lipid Peroxidation and Nitrite Levels in Rat\u2019s Brain Striatum in an Experimental Model of Parkinson\u2019s Disease. J. Isfahan Med. School. 33 (336), 780\u2013791 (2015).","journal-title":"J. Isfahan Med. School"},{"key":"66128_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuroscience.2013.09.042","volume":"256","author":"AT Goes","year":"2014","unstructured":"Goes, A. T. et al. Neuroprotective effects of swimming training in a mouse model of Parkinson\u2019s disease induced by 6-hydroxydopamine. Neuroscience 256, 61\u201371 (2014).","journal-title":"Neuroscience"},{"key":"66128_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.parkreldis.2019.07.031","volume":"66","author":"D Santos Garc\u00eda","year":"2019","unstructured":"Santos Garc\u00eda, D. et al. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson\u2019s disease patients: Results from the COPPADIS Study Cohort. Parkinsonism Relat. Disord. 66, 151\u2013157 (2019).","journal-title":"Parkinsonism Relat. Disord"},{"issue":"1","key":"66128_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.21037\/qims.2019.10.17","volume":"10","author":"R Xu","year":"2019","unstructured":"Xu, R. et al. Longitudinal volume changes of hippocampal subfields and cognitive decline in Parkinson\u2019s disease. Quant. Imaging Med. Surg. 10 (1), 220\u2013232 (2019).","journal-title":"Quant. Imaging Med. Surg."},{"issue":"12","key":"66128_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30(12), 1591\u2013601 (2015).","journal-title":"Mov. Disord."},{"issue":"8","key":"66128_CR6","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27392","volume":"33","author":"I Ortu\u00f1o-Lizar\u00e1n","year":"2018","unstructured":"Ortu\u00f1o-Lizar\u00e1n, I. et al. Phosphorylated \u03b1-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity. Mov. Disord. 33 (8), 1315\u20131324 (2018).","journal-title":"Mov. Disord."},{"key":"66128_CR7","unstructured":"Dorsey ER, Elbaz A, Nichols E, Abbasi N, Abd-Allah F, Abdelalim A, et al. Global,regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 17(11), 939\u2009\u2013\u200953 (2018)."},{"issue":"1\u20132","key":"66128_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/jop.2016.0180","volume":"34","author":"L De Groef","year":"2018","unstructured":"De Groef, L. & Cordeiro, M. F. Is the eye an extension of the brain in central nervous system disease?. J. Ocul. Pharmacol. Ther. 34(1\u20132), 129\u201333 (2018).","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"5","key":"66128_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.25897","volume":"88","author":"I Ortu\u00f1o-Lizar\u00e1n","year":"2020","unstructured":"Ortu\u00f1o-Lizar\u00e1n, I. et al. Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson Disease. Ann. Neurol. 88 (5), 893\u2013906 (2020).","journal-title":"Ann. Neurol."},{"key":"66128_CR10","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Zhang, X., Yue, Y. & Tian, T. Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson\u2019s Disease? Front. NeuroSci. 15\u20132021 (2022).","DOI":"10.3389\/fnins.2021.799526"},{"issue":"1","key":"66128_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London, A., Benhar, I. & Schwartz, M. The retina as a window to the brain\u2014from eye research to CNS disorders. Nat. Reviews Neurol. 9 (1), 44\u201353 (2013).","journal-title":"Nat. Reviews Neurol."},{"issue":"2","key":"66128_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12640-011-9261-z","volume":"21","author":"T Archer","year":"2012","unstructured":"Archer, T. & Fredriksson, A. Delayed exercise-induced functional and neurochemical partial restoration following MPTP. Neurotox. Res. 21 (2), 210\u2013221 (2012).","journal-title":"Neurotox. Res."},{"issue":"1","key":"66128_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.29252\/shefa.8.1.120","volume":"8","author":"Z Rezaee","year":"2019","unstructured":"Rezaee, Z., Marandi, M., Alaei, H. & Esfarjani, F. Molecular Mechanisms of Parkinson\u2019s Disease. Neurosci. J. Shefaye Khatam. 8 (1), 120\u2013128 (2019).","journal-title":"Neurosci. J. Shefaye Khatam"},{"key":"66128_CR14","doi-asserted-by":"crossref","unstructured":"Haeusler, G. & Lindner, M. Coherence radar and Spectral radar- new tools for dermatological diagnosis. J. Biomed. Opt. 3(1), (1998).","DOI":"10.1117\/1.429899"},{"issue":"4","key":"66128_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10792-018-0873-7","volume":"39","author":"D Gulmez Sevim","year":"2019","unstructured":"Gulmez Sevim, D. et al. Retinal vessel diameter obtained by optical coherence tomography is spared in Parkinson\u2019s disease. Int. Ophthalmol. 39 (4), 813\u2013819 (2019).","journal-title":"Int. Ophthalmol."},{"issue":"2","key":"66128_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/jamaophthalmol.2020.5730","volume":"139","author":"CB Robbins","year":"2021","unstructured":"Robbins, C. B. et al. Characterization of Retinal Microvascular and Choroidal Structural Changes in Parkinson Disease. JAMA Ophthalmol. 139 (2), 182\u2013188 (2021).","journal-title":"JAMA Ophthalmol."},{"issue":"Suppl 2","key":"66128_CR17","doi-asserted-by":"publisher","first-page":"Ii11","DOI":"10.1007\/PL00007755","volume":"247","author":"DJ Brooks","year":"2000","unstructured":"Brooks, D. J. Morphological and functional imaging studies on the diagnosis and progression of Parkinson\u2019s disease. J. Neurol. 247 (Suppl 2), Ii11\u2013Ii18 (2000).","journal-title":"J. Neurol."},{"issue":"2","key":"66128_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.parkreldis.2008.03.005","volume":"15","author":"P Jokinen","year":"2009","unstructured":"Jokinen, P. et al. Impaired cognitive performance in Parkinson\u2019s disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat. Disord. 15 (2), 88\u201393 (2009).","journal-title":"Parkinsonism Relat. Disord"},{"issue":"Pt 4","key":"66128_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/brain\/awh088","volume":"127","author":"EJ Burton","year":"2004","unstructured":"Burton, E. J., McKeith, I. G., Burn, D. J., Williams, E. D. & O\u2019Brien, J. T. Cerebral atrophy in Parkinson\u2019s disease with and without dementia: a comparison with Alzheimer\u2019s disease, dementia with Lewy bodies and controls. Brain 127 (Pt 4), 791\u2013800 (2004).","journal-title":"Brain"},{"issue":"2","key":"66128_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1212\/01.WNL.0000149510.41793.50","volume":"64","author":"A Nagano-Saito","year":"2005","unstructured":"Nagano-Saito, A. et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64 (2), 224\u2013229 (2005).","journal-title":"Neurology"},{"issue":"2","key":"66128_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/archneur.62.2.281","volume":"62","author":"C Summerfield","year":"2005","unstructured":"Summerfield, C. et al. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch. Neurol. 62 (2), 281\u2013285 (2005).","journal-title":"Arch. Neurol."},{"issue":"2","key":"66128_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jmri.28414","volume":"57","author":"N He","year":"2023","unstructured":"He, N., Chen, Y., LeWitt, P. A., Yan, F. & Haacke, E. M. Application of Neuromelanin MR Imaging in Parkinson Disease. J. Magn. Reson. Imaging. 57 (2), 337\u2013352 (2023).","journal-title":"J. Magn. Reson. Imaging"},{"key":"66128_CR23","doi-asserted-by":"publisher","first-page":"116935","DOI":"10.1016\/j.neuroimage.2020.116935","volume":"218","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Optimizing neuromelanin contrast in the substantia nigra and locus coeruleus using a magnetization transfer contrast prepared 3D gradient recalled echo sequence. Neuroimage 218, 116935 (2020).","journal-title":"Neuroimage"},{"issue":"3","key":"66128_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/archneur.60.3.337","volume":"60","author":"C Zarow","year":"2003","unstructured":"Zarow, C., Lyness, S. A., Mortimer, J. A. & Chui, H. C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch. Neurol. 60 (3), 337\u2013341 (2003).","journal-title":"Arch. Neurol."},{"key":"66128_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuroimage.2015.02.045","volume":"112","author":"J Langley","year":"2015","unstructured":"Langley, J. et al. A multicontrast approach for comprehensive imaging of substantia nigra. Neuroimage 112, 7\u201313 (2015).","journal-title":"Neuroimage"},{"issue":"8","key":"66128_CR26","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1007\/s00330-020-07582-2","volume":"31","author":"E Manfrini","year":"2021","unstructured":"Manfrini, E. et al. From research to clinical practice: a European neuroradiological survey on quantitative advanced MRI implementation. Eur. Radiol. 31 (8), 6334\u20136341 (2021).","journal-title":"Eur. Radiol."},{"key":"66128_CR27","doi-asserted-by":"crossref","unstructured":"Clement, P. et al. A Beginner\u2019s Guide to Arterial Spin Labeling (ASL) Image Processing. Front. Radiol. 2\u20132022 (2022).","DOI":"10.3389\/fradi.2022.929533"},{"issue":"1","key":"66128_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/mrm.25197","volume":"73","author":"DC Alsop","year":"2015","unstructured":"Alsop, D. C. et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn. Reson. Med. 73(1), 102\u201316 (2015).","journal-title":"Magn. Reson. Med."},{"key":"66128_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.892374","volume":"16","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. The convergent and divergent patterns in brain perfusion between Alzheimer\u2019s disease and Parkinson\u2019s disease with dementia: An ASL MRI study. Front. Neurosci. 16, 892374 (2022).","journal-title":"Front. Neurosci."},{"key":"66128_CR30","doi-asserted-by":"crossref","unstructured":"Li, L. et al. Altered cerebral perfusion in Parkinson\u2019s disease patients with anxiety: an arterial spin labeling MRI study. Front. Neurol. 16\u20132025 (2025).","DOI":"10.3389\/fneur.2025.1583451"},{"issue":"11","key":"66128_CR31","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/neuonc\/noy095","volume":"20","author":"A Falk Delgado","year":"2018","unstructured":"Falk Delgado, A., De Luca, F., van Westen, D. & Falk Delgado, A. Arterial spin labeling MR imaging for differentiation between high- and low-grade glioma-a meta-analysis. Neuro Oncol. 20(11), 1450\u201361 (2018).","journal-title":"Neuro Oncol."},{"issue":"s1","key":"66128_CR32","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.3233\/JPD-223245","volume":"12","author":"MH Terkelsen","year":"2022","unstructured":"Terkelsen, M. H. et al. Neuroinflammation and immune changes in prodromal Parkinson\u2019s disease and other synucleinopathies. J. Parkinsons Dis. 12(s1), S149-s63 (2022).","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"66128_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41531-024-00713-2","volume":"10","author":"W Hu","year":"2024","unstructured":"Hu, W. et al. Metabolic profiling reveals circulating biomarkers associated with incident and prevalent Parkinson\u2019s disease. NPJ Parkinsons Dis. 10 (1), 130 (2024).","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"66128_CR34","doi-asserted-by":"publisher","first-page":"20941","DOI":"10.1038\/s41598-024-70165-4","volume":"14","author":"V Dentamaro","year":"2024","unstructured":"Dentamaro, V., Impedovo, D., Musti, L., Pirlo, G. & Taurisano, P. Enhancing early Parkinson\u2019s disease detection through multimodal deep learning and explainable AI: insights from the PPMI database. Sci. Rep. 14 (1), 20941 (2024).","journal-title":"Sci. Rep."},{"key":"66128_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2025.112063","author":"N Chowdhury","year":"2025","unstructured":"Chowdhury, N., Das, U., Chowdhury, A., Sazzad, S. & Das, P. Multimodal approach for early diagnosis of Parkinson\u2019s disease using PET imaging, tremor detection, and machine learning. Psychiatry Res. Neuroimaging https:\/\/doi.org\/10.1016\/j.pscychresns.2025.112063 (2025).","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"Suppl 1","key":"66128_CR36","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.parkreldis.2015.09.048","volume":"22","author":"M Delenclos","year":"2016","unstructured":"Delenclos, M., Jones, D. R., McLean, P. J. & Uitti, R. J. Biomarkers in Parkinson\u2019s disease: Advances and strategies. Parkinsonism Relat. Disord. 22 (Suppl 1), S106\u2013S110 (2016).","journal-title":"Parkinsonism Relat. Disord"},{"key":"66128_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00305","volume":"10","author":"R He","year":"2018","unstructured":"He, R. et al. Recent advances in biomarkers for Parkinson\u2019s disease. Front. Aging Neurosci. 10, 305 (2018).","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"66128_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41531-024-00828-6","volume":"10","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Multimodal neuroimaging-based prediction of Parkinson\u2019s disease with mild cognitive impairment using machine learning technique. npj Parkinson\u2019s Disease. 10 (1), 218 (2024).","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"4","key":"66128_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41582-022-00618-9","volume":"18","author":"J-Y Lee","year":"2022","unstructured":"Lee, J-Y. et al. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease. Nat. Reviews Neurol. 18 (4), 203\u2013220 (2022).","journal-title":"Nat. Reviews Neurol."},{"issue":"9","key":"66128_CR40","doi-asserted-by":"publisher","first-page":"e0237078","DOI":"10.1371\/journal.pone.0237078","volume":"15","author":"A Uchida","year":"2020","unstructured":"Uchida, A. et al. Correlation between brain volume and retinal photoreceptor outer segment volume in normal aging and neurodegenerative diseases. PLoS One. 15 (9), e0237078 (2020).","journal-title":"PLoS One"},{"issue":"4","key":"66128_CR41","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3233\/JPD-212676","volume":"11","author":"GL Brown","year":"2021","unstructured":"Brown, G. L. et al. Choroidal thickness correlates with clinical and imaging metrics of Parkinson\u2019s disease: A pilot study. J. Parkinsons Dis. 11(4), 1857\u201368 (2021).","journal-title":"J. Parkinsons Dis."},{"issue":"10","key":"66128_CR42","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1007\/s00415-020-09925-x","volume":"267","author":"A Marques","year":"2020","unstructured":"Marques, A. et al. Visual hallucinations and illusions in Parkinson\u2019s disease: the role of ocular pathology. J. Neurol. 267 (10), 2829\u20132841 (2020).","journal-title":"J. Neurol."},{"issue":"5","key":"66128_CR43","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/1533317515628053","volume":"31","author":"JA Pillai","year":"2016","unstructured":"Pillai, J. A. et al. Retinal Nerve Fiber Layer Thinning in Alzheimer\u2019s Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson\u2019s Disease, and Non-Alzheimer\u2019s Dementia. Am. J. Alzheimers Dis. Other Demen. 31 (5), 430\u2013436 (2016).","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"key":"66128_CR44","doi-asserted-by":"publisher","first-page":"105310","DOI":"10.1016\/j.pdpdt.2025.105310","volume":"57","author":"F Nikparast","year":"2025","unstructured":"Nikparast, F. et al. OCT-based retinal biomarkers forecast central nervous system structural decline in Parkinson\u2019s disease: A longitudinal multimodal study within the Persian Cohort. Photodiagnosis Photodyn Ther. 57, 105310 (2025).","journal-title":"Photodiagnosis Photodyn Ther."},{"key":"66128_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2025.104632","volume":"54","author":"F Nikparast","year":"2025","unstructured":"Nikparast, F., Ganji, Z., Zare, H. & Akbari-Sharak, N. Systematic review and network meta-analysis of retinal imaging biomarkers in neurodegenerative diseases: Correlation with brain changes. Photodiagnosis Photodyn. Ther. 54, 104632 (2025).","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"66128_CR46","volume-title":"Statistical Parametric Mapping: The Analysis of Functional Brain Images","author":"WD Penny","year":"2011","unstructured":"Penny, W. D., Friston, K. J., Ashburner, J. T., Kiebel, S. J. & Nichols, T. E. Statistical Parametric Mapping: The Analysis of Functional Brain Images (Academic Press, 2011)."},{"key":"66128_CR47","doi-asserted-by":"crossref","unstructured":"Gaser, C., Dahnke, R., Thompson, P. M., Kurth, F. & Luders, E. The Alzheimer\u2019s Disease Neuroimaging I. CAT: a computational anatomy toolbox for the analysis of structural MRI data. Gigascience 13, (2024).","DOI":"10.1093\/gigascience\/giae049"},{"issue":"9","key":"66128_CR48","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov, A. et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn. Reson. Imaging. 30 (9), 1323\u20131341 (2012).","journal-title":"Magn. Reson. Imaging"},{"key":"66128_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00196","volume":"Volume 8","author":"IU Isaias","year":"2016","unstructured":"Isaias, I. U. et al. Neuromelanin imaging and dopaminergic loss in Parkinson\u2019s disease. Front. Aging Neurosci. 8, 2016 (2016).","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"66128_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41531-023-00469-1","volume":"9","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Common and distinct roles of amygdala subregional functional connectivity in non-motor symptoms of Parkinson\u2019s disease. npj Parkinson\u2019s Disease. 9 (1), 28 (2023).","journal-title":"npj Parkinson\u2019s Disease"},{"key":"66128_CR51","doi-asserted-by":"crossref","unstructured":"Wang, S. et al. Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson\u2019s disease with freezing of gait. Front. Aging Neurosci. 15 (2023).","DOI":"10.3389\/fnagi.2023.1060935"},{"issue":"2","key":"66128_CR52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging. 24 (2), 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"66128_CR53","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes, C. H., Del Tredici, K. & Braak, H. Parkinson\u2019s disease: A dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 33(6), 599\u2013614 (2007).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"66128_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2023.100074","volume":"9","author":"KY Yamashita","year":"2023","unstructured":"Yamashita, K. Y., Bhoopatiraju, S., Silverglate, B. D. & Grossberg, G. T. Biomarkers in Parkinson\u2019s disease: A state of the art review. Biomarkers in Neuropsychiatry 9, 100074 (2023).","journal-title":"Biomarkers in Neuropsychiatry"},{"issue":"1","key":"66128_CR55","doi-asserted-by":"publisher","first-page":"e1174","DOI":"10.1002\/prp2.1174","volume":"12","author":"KKY Ikenaka","year":"2024","unstructured":"Ikenaka, K. K. Y. et al. Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson\u2019s disease patients. Pharmacol. Res. Perspect. 12 (1), e1174 (2024).","journal-title":"Pharmacol. Res. Perspect."},{"key":"66128_CR56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.parkreldis.2018.06.016","volume":"56","author":"J Matlach","year":"2018","unstructured":"Matlach, J. et al. Retinal changes in Parkinson\u2019s disease and glaucoma. Parkinsonism Relat. Disord. 56, 41\u201346 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"66128_CR57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JPD-171184","volume":"8","author":"L-J Ma","year":"2018","unstructured":"Ma, L-J. et al. Progressive Changes in the Retinal Structure of Patients with Parkinson\u2019s Disease. J. Parkinson\u2019s Disease. 8 (1), 85\u201392 (2018).","journal-title":"J. Parkinson\u2019s Disease"},{"issue":"3","key":"66128_CR58","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10072-018-3244-2","volume":"39","author":"M Unlu","year":"2018","unstructured":"Unlu, M., Gulmez Sevim, D., Gultekin, M. & Karaca, C. Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson\u2019s disease. Neurol. Sci. 39 (3), 533\u2013541 (2018).","journal-title":"Neurol. Sci."},{"issue":"3","key":"66128_CR59","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.kjms.2017.11.006","volume":"34","author":"TS Aydin","year":"2018","unstructured":"Aydin, T. S. et al. Optical coherence tomography findings in Parkinson\u2019s disease. Kaohsiung J. Med. Sci. 34 (3), 166\u2013171 (2018).","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"1","key":"66128_CR60","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5301\/ejo.5000338","volume":"24","author":"A Sen","year":"2014","unstructured":"Sen, A., Tugcu, B., Coskun, C., Ekinci, C. & Nacaroglu, S. A. Effects of levodopa on retina in Parkinson disease. Eur. J. Ophthalmol. 24 (1), 114\u2013119 (2014).","journal-title":"Eur. J. Ophthalmol."},{"issue":"2","key":"66128_CR61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/WNO.0000000000000591","volume":"38","author":"DG Sevim","year":"2018","unstructured":"Sevim, D. G. et al. Evaluation of retinal changes in progressive supranuclear palsy and Parkinson disease. J. Neuroophthalmol. 38(2), 151\u20135 (2018).","journal-title":"J. Neuroophthalmol."},{"issue":"4","key":"66128_CR62","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/WNL.42.4.887","volume":"42","author":"MJ Price","year":"1992","unstructured":"Price, M. J., Feldman, R. G., Adelberg, D. & Kayne, H. Abnormalities in color vision and contrast sensitivity in Parkinson\u2019s disease. Neurology 42(4), 887\u201390 (1992).","journal-title":"Neurology"},{"issue":"11","key":"66128_CR63","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00702-009-0292-z","volume":"116","author":"I Bodis-Wollner","year":"2009","unstructured":"Bodis-Wollner, I. Retinopathy in Parkinson Disease. J. Neural Transm (Vienna). 116 (11), 1493\u20131501 (2009).","journal-title":"J. Neural Transm (Vienna)"},{"issue":"11","key":"66128_CR64","first-page":"2473","volume":"31","author":"C Harnois","year":"1990","unstructured":"Harnois, C. & Di Paolo, T. Decreased dopamine in the retinas of patients with Parkinson\u2019s disease. Invest. Ophthalmol. Vis. Sci. 31 (11), 2473\u20132475 (1990).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"24","key":"66128_CR65","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1016\/S0042-6989(97)00129-6","volume":"37","author":"MB Djamgoz","year":"1997","unstructured":"Djamgoz, M. B., Hankins, M. W., Hirano, J. & Archer, S. N. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res. 37(24), 3509\u201329 (1997).","journal-title":"Vision Res."},{"key":"66128_CR66","first-page":"297","volume":"67","author":"I Bodis-Wollner","year":"1990","unstructured":"Bodis-Wollner, I. The visual system in Parkinson\u2019s disease. Res. Publ Assoc. Res. Nerv. Ment Dis. 67, 297\u2013316 (1990).","journal-title":"Res. Publ Assoc. Res. Nerv. Ment Dis."},{"key":"66128_CR67","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/112067210701700520","volume":"17","author":"G Yavas","year":"2007","unstructured":"Yavas, G., Yilmaz, O., Kusbeci, T. & Ozturk, F. The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. Eur. J. Ophthalmol. 17, 812\u20136 (2007).","journal-title":"Eur. J. Ophthalmol."},{"key":"66128_CR68","doi-asserted-by":"crossref","unstructured":"Antal, A., Paulus, W. & Bodis-Wollner, I. Visuo-Cognitive Dysfunctions in Parkinson\u2019s Disease. 237\u2009\u2013\u200948 (2005).","DOI":"10.1201\/9780203508596.ch23"},{"issue":"2","key":"66128_CR69","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1124\/jpet.102.039875","volume":"303","author":"A Newman-Tancredi","year":"2002","unstructured":"Newman-Tancredi, A. et al. Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. II. Agonist and Antagonist Properties at Subtypes of Dopamine D2-Like Receptor and \u03b11\/\u03b12-Adrenoceptor. J. Pharmacol. Exp. Ther. 303 (2), 805\u2013814 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"66128_CR70","doi-asserted-by":"publisher","first-page":"e14437","DOI":"10.1002\/alz.14437","volume":"21","author":"Y-S Lee","year":"2025","unstructured":"Lee, Y-S. et al. Interocular retinal asymmetry and cognitive frailty: A prospective cohort study. Alzheimer\u2019s Dement. 21 (2), e14437 (2025).","journal-title":"Alzheimer\u2019s Dement."},{"issue":"6","key":"66128_CR71","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e50","volume":"36","author":"SU Baek","year":"2021","unstructured":"Baek, S. U., Kang, S. Y., Kwon, S., Park, I. W. & Suh, W. Motor asymmetry and interocular retinal thickness in Parkinson\u2019s disease. J. Korean Med. Sci. 36(6), e50 (2021).","journal-title":"J. Korean Med. Sci."},{"key":"66128_CR72","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.baga.2013.01.031","volume":"3","author":"I Bodis-Wollner","year":"2013","unstructured":"Bodis-Wollner, I., Ding, Y., Shrier, E., Selesnick, I. & Glazman, S. Asymmetry of the retina in the two eyes in Parkinson Disease. Basal Ganglia. 3, 50 (2013).","journal-title":"Basal Ganglia"},{"issue":"3","key":"66128_CR73","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.4103\/0028-3886.349658","volume":"70","author":"P Mailankody","year":"2022","unstructured":"Mailankody, P. et al. Retinal Changes in Parkinson\u2019s Disease: A Longitudinal Follow-up Study. Neurol. India. 70 (3), 1149\u20131153 (2022).","journal-title":"Neurol. India"},{"issue":"4","key":"66128_CR74","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/eye.2013.4","volume":"27","author":"M Satue","year":"2013","unstructured":"Satue, M. et al. Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson\u2019s disease patients. Eye (Lond). 27 (4), 507\u2013514 (2013).","journal-title":"Eye (Lond)"},{"issue":"5","key":"66128_CR75","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009658","volume":"6","author":"V Polo","year":"2016","unstructured":"Polo, V. et al. Visual dysfunction and its correlation with retinal changes in patients with Parkinson\u2019s disease: An observational cross-sectional study. BMJ Open 6(5), e009658 (2016).","journal-title":"BMJ Open"},{"issue":"7","key":"66128_CR76","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1177\/1352458510397414","volume":"17","author":"E Garcia-Martin","year":"2011","unstructured":"Garcia-Martin, E. et al. Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients. Mult Scler. 17 (7), 830\u2013837 (2011).","journal-title":"Mult Scler."},{"issue":"1","key":"66128_CR77","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","volume":"15","author":"P Ge","year":"2020","unstructured":"Ge, P., Dawson, V. L. & Dawson, T. M. PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease. Mol. Neurodegeneration. 15 (1), 20 (2020).","journal-title":"Mol. Neurodegeneration"},{"issue":"9","key":"66128_CR78","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1167\/iovs.07-0024","volume":"48","author":"Y Ito","year":"2007","unstructured":"Ito, Y. et al. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations. Invest. Ophthalmol. Vis. Sci. 48 (9), 4079\u20134086 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"66128_CR79","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1755-3768.2008.01469.x","volume":"88","author":"D Milea","year":"2010","unstructured":"Milea, D. et al. Axonal loss occurs early in dominant optic atrophy. Acta Ophthalmol. 88(3), 342\u20136 (2010).","journal-title":"Acta Ophthalmol."},{"issue":"2","key":"66128_CR80","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man, P., Griffiths, P. G. & Chinnery, P. F. Mitochondrial optic neuropathies - Disease mechanisms and therapeutic strategies. Prog. Retin. Eye Res. 30(2), 81\u2013114 (2011).","journal-title":"Prog. Retin. Eye Res."},{"key":"66128_CR81","doi-asserted-by":"crossref","unstructured":"Liu, R-P. et al. Changes of brain structure and structural covariance networks in Parkinson\u2019s disease associated cognitive impairment. Front. Aging Neurosci. 16 (2024).","DOI":"10.3389\/fnagi.2024.1449276"},{"issue":"6333","key":"66128_CR82","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1126\/science.aam6808","volume":"356","author":"T Kitamura","year":"2017","unstructured":"Kitamura, T. et al. Engrams and circuits crucial for systems consolidation of a memory. Science 356 (6333), 73\u201378 (2017).","journal-title":"Science"},{"issue":"6061","key":"66128_CR83","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.1210125","volume":"334","author":"J Suh","year":"2011","unstructured":"Suh, J., Rivest, A. J., Nakashiba, T., Tominaga, T. & Tonegawa, S. Entorhinal cortex layer III input to the hippocampus is crucial for temporal association memory. Science 334 (6061), 1415\u20131420 (2011).","journal-title":"Science"},{"issue":"4","key":"66128_CR84","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1523\/JNEUROSCI.4166-03.2004","volume":"24","author":"KM Rodrigue","year":"2004","unstructured":"Rodrigue, K. M. & Raz, N. Shrinkage of the entorhinal cortex over five years predicts memory performance in healthy adults. J. Neurosci. 24 (4), 956\u2013963 (2004).","journal-title":"J. Neurosci."},{"issue":"6","key":"66128_CR85","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.14336\/AD.2018.1116","volume":"10","author":"X Jia","year":"2019","unstructured":"Jia, X. et al. Entorhinal cortex atrophy in early, drug-naive Parkinson\u2019s disease with mild cognitive impairment. Aging Dis. 10(6), 1221\u201332 (2019).","journal-title":"Aging Dis."},{"key":"66128_CR86","doi-asserted-by":"crossref","unstructured":"Yin, W. et al. Abnormal cortical atrophy and functional connectivity are associated with depression in Parkinson\u2019s disease. Front. Aging Neurosci. 14 (2022).","DOI":"10.3389\/fnagi.2022.957997"},{"key":"66128_CR87","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pscychresns.2016.03.002","volume":"250","author":"P Huang","year":"2016","unstructured":"Huang, P. et al. Cortical abnormalities in Parkinson\u2019s disease patients and relationship to depression: A surface-based morphometry study. Psychiatry Research: Neuroimaging. 250, 24\u201328 (2016).","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"66128_CR88","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bandc.2016.11.001","volume":"111","author":"A Hanganu","year":"2017","unstructured":"Hanganu, A. et al. Depressive symptoms in Parkinson\u2019s disease correlate with cortical atrophy over time. Brain Cogn. 111, 127\u201333 (2017).","journal-title":"Brain Cogn."},{"issue":"2","key":"66128_CR89","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14582","volume":"30","author":"J Yuan","year":"2024","unstructured":"Yuan, J. et al. Alterations in cortical volume and complexity in Parkinson\u2019s disease with depression. CNS Neurosci. Ther. 30(2), e14582 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"66128_CR90","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/B978-0-444-64196-0.00013-3","volume":"166","author":"BA Vogt","year":"2019","unstructured":"Vogt, B. A. Cingulate cortex in Parkinson\u2019s disease. Handb. Clin. Neurol. 166, 253\u2013266 (2019).","journal-title":"Handb. Clin. Neurol."},{"issue":"8","key":"66128_CR91","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/jnnp-2012-304126","volume":"84","author":"M Zarei","year":"2013","unstructured":"Zarei, M. et al. Cortical thinning is associated with disease stages and dementia in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry. 84 (8), 875\u2013882 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"66128_CR92","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.parkreldis.2014.04.005","volume":"20","author":"C Ohtsuka","year":"2014","unstructured":"Ohtsuka, C. et al. Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat. Disord. 20 (7), 755\u2013760 (2014).","journal-title":"Parkinsonism Relat. Disord"},{"issue":"7","key":"66128_CR93","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/mds.26201","volume":"30","author":"G Castellanos","year":"2015","unstructured":"Castellanos, G. et al. Automated neuromelanin imaging as a diagnostic biomarker for Parkinson\u2019s disease. Mov. Disord. 30 (7), 945\u2013952 (2015).","journal-title":"Mov. Disord"},{"issue":"11","key":"66128_CR94","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/mds.27502","volume":"33","author":"Y Xing","year":"2018","unstructured":"Xing, Y., Sapuan, A., Dineen, R. A. & Auer, D. P. Life span pigmentation changes of the substantia nigra detected by neuromelanin-sensitive MRI. Mov. Disord. 33 (11), 1792\u20131799 (2018).","journal-title":"Mov. Disord."},{"issue":"1","key":"66128_CR95","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.1977.00500130053010","volume":"34","author":"PL McGeer","year":"1977","unstructured":"McGeer, P. L., McGeer, E. G. & Suzuki, J. S. Aging and extrapyramidal function. Arch. Neurol. 34 (1), 33\u201335 (1977).","journal-title":"Arch. Neurol."},{"issue":"5","key":"66128_CR96","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0969-8051(02)00303-7","volume":"29","author":"K-H Ma","year":"2002","unstructured":"Ma, K-H. et al. Dual SPECT of dopamine system using [99mTc] TRODAT-1 and [123I] IBZM in normal and 6-OHDA-lesioned formosan rock monkeys. Nucl. Med. Biol. 29 (5), 561\u2013567 (2002).","journal-title":"Nucl. Med. Biol."},{"key":"66128_CR97","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf204","author":"J-B P\u00e9rot","year":"2025","unstructured":"P\u00e9rot, J.-B. et al. Longitudinal neuromelanin changes in prodromal and early Parkinson\u2019s disease in humans and rat model. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcaf204 (2025).","journal-title":"Brain Commun."},{"issue":"5","key":"66128_CR98","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley, J. M. & Lees, A. J. Ageing and Parkinson\u2019s disease: Substantia nigra regional selectivity. Brain 114(5), 2283\u2013301 (1991).","journal-title":"Brain"},{"issue":"4","key":"66128_CR99","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/archneur.63.4.584","volume":"63","author":"S Greffard","year":"2006","unstructured":"Greffard, S. et al. Motor score of the unified Parkinson disease rating scale as a good predictor of Lewy body\u2013associated neuronal loss in the substantia nigra. Arch. Neurol. 63 (4), 584\u2013588 (2006).","journal-title":"Arch. Neurol."},{"issue":"3","key":"66128_CR100","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s00330-020-07240-7","volume":"31","author":"SJ Cho","year":"2021","unstructured":"Cho, S. J. et al. Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson\u2019s disease and factor analysis for its heterogeneity: a systematic review and meta-analysis. Eur. Radiol. 31 (3), 1268\u20131280 (2021).","journal-title":"Eur. Radiol."},{"key":"66128_CR101","doi-asserted-by":"crossref","unstructured":"Herculano-Houzel, V. A. S. Energy supply per neuron is constrained by capillary density in the mouse brain. Front. Integr. Nuerosci. 16 (2022).","DOI":"10.3389\/fnint.2022.760887"},{"issue":"4","key":"66128_CR102","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.neuron.2018.07.007","volume":"99","author":"F Zhu","year":"2018","unstructured":"Zhu, F. et al. Architecture of the mouse brain synaptome. Neuron 99(4), 781\u201399.e10 (2018).","journal-title":"Neuron"},{"issue":"2","key":"66128_CR103","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0889-8537(01)00012-8","volume":"20","author":"MS Vavilala","year":"2002","unstructured":"Vavilala, M. S., Lee, L. A. & Lam, A. M. Cerebral blood flow and vascular physiology. Anesthesiol. Clin. North Am. 20(2), 247\u201364 (2002).","journal-title":"Anesthesiol. Clin. North Am."},{"issue":"3","key":"66128_CR104","doi-asserted-by":"publisher","first-page":"031411","DOI":"10.1117\/1.NPh.3.3.031411","volume":"3","author":"S Fantini","year":"2016","unstructured":"Fantini, S., Sassaroli, A., Tgavalekos, K. T. & Kornbluth, J. Cerebral blood flow and autoregulation: current measurement techniques and prospects for noninvasive optical methods. Neurophotonics 3 (3), 031411 (2016).","journal-title":"Neurophotonics"},{"key":"66128_CR105","doi-asserted-by":"publisher","first-page":"101594","DOI":"10.1016\/j.nicl.2018.11.004","volume":"21","author":"F Albrecht","year":"2019","unstructured":"Albrecht, F., Ballarini, T., Neumann, J. & Schroeter, M. L. FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson\u2019s disease: a whole-brain multimodal imaging meta-analysis. NeuroImage: Clin. 21, 101594 (2019).","journal-title":"NeuroImage: Clin."},{"issue":"4","key":"66128_CR106","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/jmri.22515","volume":"33","author":"K Kamagata","year":"2011","unstructured":"Kamagata, K. et al. Posterior hypoperfusion in Parkinson\u2019s disease with and without dementia measured with arterial spin labeling MRI. J. Magn. Reson. Imaging. 33 (4), 803\u2013807 (2011).","journal-title":"J. Magn. Reson. Imaging"},{"issue":"16_part_2","key":"66128_CR107","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1212\/01.wnl.0000304050.05332.9c","volume":"70","author":"C Huang","year":"2008","unstructured":"Huang, C. et al. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 70 (16_part_2), 1470\u20131477 (2008).","journal-title":"Neurology"},{"issue":"4","key":"66128_CR108","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp-2016-313918","volume":"88","author":"MJ Firbank","year":"2017","unstructured":"Firbank, M. J. et al. Cerebral glucose metabolism and cognition in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. J. Neurol. Neurosurg. Psychiatry 88(4), 310\u20136 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"66128_CR109","doi-asserted-by":"crossref","unstructured":"Pelizzari, L. et al. Parietal Perfusion Alterations in Parkinson\u2019s Disease Patients Without Dementia. Front. Neurol. 11\u20132020 (2020).","DOI":"10.3389\/fneur.2020.00562"},{"key":"66128_CR110","doi-asserted-by":"crossref","unstructured":"Taylor, K. I., Sambataro, F., Boess, F., Bertolino, A. & Dukart, J. Progressive Decline in Gray and White Matter Integrity in de novo Parkinson\u2019s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data. Front. Aging Neurosci. 10\u20132018 (2018).","DOI":"10.3389\/fnagi.2018.00318"},{"issue":"7","key":"66128_CR111","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/jnr.24617","volume":"98","author":"H Sanjari Moghaddam","year":"2020","unstructured":"Sanjari Moghaddam, H., Dolatshahi, M., Mohebi, F. & Aarabi, M. H. Structural white matter alterations as compensatory mechanisms in Parkinson\u2019s disease: A systematic review of diffusion tensor imaging studies. J. Neurosci. Res. 98 (7), 1398\u20131416 (2020).","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"66128_CR112","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-025-00975-4","volume":"11","author":"Z Zhu","year":"2025","unstructured":"Zhu, Z. et al. Identifying brain degeneration patterns in early-stage Parkinson\u2019s disease: a multimodal MRI study. npj Parkinson\u2019s Disease. 11 (1), 93 (2025).","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"1","key":"66128_CR113","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41531-023-00592-z","volume":"9","author":"K Yang","year":"2023","unstructured":"Yang, K. et al. White matter changes in Parkinson\u2019s disease. NPJ Parkinsons Dis. 9 (1), 150 (2023).","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"66128_CR114","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s11357-024-01428-1","volume":"47","author":"Y-Q Jiang","year":"2025","unstructured":"Jiang, Y-Q. et al. White matter lesions contribute to motor and non-motor disorders in Parkinson\u2019s disease: a critical review. GeroScience 47 (1), 591\u2013609 (2025).","journal-title":"GeroScience"},{"key":"66128_CR115","doi-asserted-by":"crossref","unstructured":"Shih, Y-C., Tseng, W-Y-I. & Montaser-Kouhsari, L. Recent advances in using diffusion tensor imaging to study white matter alterations in Parkinson\u2019s disease: A mini review. Front. Aging Neurosci.14\u20132022 (2023).","DOI":"10.3389\/fnagi.2022.1018017"},{"issue":"1","key":"66128_CR116","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41531-024-00758-3","volume":"10","author":"C Owens-Walton","year":"2024","unstructured":"Owens-Walton, C. et al. A worldwide study of white matter microstructural alterations in people living with Parkinson\u2019s disease. npj Parkinson\u2019s Disease. 10 (1), 151 (2024).","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"8","key":"66128_CR117","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/cells8080839","volume":"8","author":"C Andica","year":"2019","unstructured":"Andica, C. et al. Free-Water Imaging in White and Gray Matter in Parkinson\u2019s Disease. Cells 8 (8), 839 (2019).","journal-title":"Cells"},{"key":"66128_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.593026","volume":"11","author":"S Al-Bachari","year":"2020","unstructured":"Al-Bachari, S., Naish, J. H., Parker, G. J. M., Emsley, H. C. A. & Parkes, L. M. Blood-brain barrier leakage is increased in Parkinson\u2019s disease. Front. Physiol. 11, 593026 (2020).","journal-title":"Front. Physiol."},{"key":"66128_CR119","doi-asserted-by":"crossref","unstructured":"Lu, Z. et al. Multiscale Imaging Approaches to Decipher Blood-Brain Barrier Disruption in Parkinson\u2019s Disease (A Bridge to Novel Therapeutic Targets, 2025).","DOI":"10.22541\/au.174736644.44597516\/v1"},{"issue":"6","key":"66128_CR120","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/mdc3.12956","volume":"7","author":"P Linortner","year":"2020","unstructured":"Linortner, P. et al. White Matter Hyperintensities Related to Parkinson\u2019s Disease Executive Function. Mov. Disord Clin. Pract. 7 (6), 629\u2013638 (2020).","journal-title":"Mov. Disord Clin. Pract."},{"issue":"1","key":"66128_CR121","doi-asserted-by":"publisher","first-page":"10594","DOI":"10.1038\/s41598-023-37054-8","volume":"13","author":"G Hernadi","year":"2023","unstructured":"Hernadi, G. et al. White matter hyperintensities associated with impulse control disorders in Parkinson\u2019s Disease. Sci. Rep. 13 (1), 10594 (2023).","journal-title":"Sci. Rep."},{"issue":"5","key":"66128_CR122","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1177\/0271678X241305480","volume":"45","author":"M Lin","year":"2025","unstructured":"Lin, M. et al. Longitudinal changes in white matter free water in cerebral small vessel disease: Relationship to cerebral blood flow and white matter fiber alterations. J. Cereb. Blood Flow. Metabolism. 45 (5), 932\u2013944 (2025).","journal-title":"J. Cereb. Blood Flow. Metabolism"},{"key":"66128_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15040370","author":"K Siva","year":"2025","unstructured":"Siva, K., Ponnusamy, P., Chavda, V. & Montemurro, N. The effect of dopaminergic therapy in Parkinson\u2019s disease: A graph theory analysis. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci15040370 (2025).","journal-title":"Brain Sci."},{"key":"66128_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.122811","volume":"456","author":"J Zeng","year":"2024","unstructured":"Zeng, J. et al. Effect of acute levodopa challenge test on cerebral blood flow in Parkinson\u2019s disease with the supine-to-standing transcranial Doppler test. J. Neurol. Sci. 456, 122811 (2024).","journal-title":"J. Neurol. Sci."},{"key":"66128_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111237","volume":"222","author":"S Wang","year":"2025","unstructured":"Wang, S. et al. Altered resting-state cerebral blood flow and its relationship with molecular architecture in tremor dominant Parkinson\u2019s disease. Brain Res. Bull. 222, 111237 (2025).","journal-title":"Brain Res. Bull."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66128-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66128-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66128-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:04:32Z","timestamp":1789380272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66128-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66128"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-66128-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"14 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the Declaration of Helsinki and was approved by the Ethics Committee of Mashhad University of Medical Sciences (Approval Code: IR.MUMS.MEDICAL.REC.1403.318). Written informed consent was obtained from all participants prior to their inclusion in the Persian Organizational Cohort Study (POCS).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28591"}}